Engineering students, including a record number of women, have their sights set on the biomedical industry, with a 40% increase in demand for UNSW’s degree.
UNSW is home to the Graduate School of Biomedical Engineering, and the key advantage of the program is that it offers undergraduates a concurrent five-year Bachelors and Masters degree, where biomedical engineering is a strong focus that is complemented by one of nine accredited engineering degrees, such as electrical, mechanical or chemical engineering.
The rise in applications is driven by a growing public interest in the way new engineering technologies interface and help support the human body to improve quality of life.
In this area, UNSW is leading the field, with projects such as implantable bionics including the bionic eye, the development of ambulatory prosthetic devices for the Australian Paralympic team and advancements in biomaterials and regenerative medicine.
The biomedical engineering course also attracts budding entrepreneurs, due to the school’s strong links with industry. The most recent company to be launched from UNSW and the School is bioz.
Set up with initial funding from the Ignition Labs program of business incubator ATPi and matching funds from the Innovate NSW MVP program of NSW Trade and Investment, bioz’s first product will be a ‘lymphoedema compression sleeve’ which uses a patent-pending four dimensional-weaving technology and harnesses the patient’s movement to maintain compression in limbs afflicted by a buildup of tissue fluid at the surgical site, a condition that 20% of cancer survivors will face after surgery.
Visit the Webpage of Graduate School of Biomedical Engineering http://www.engineering.unsw.edu.au/biomedical-engineering/